Table 1.
Baseline patient characteristics
| All (n=1728) | Low-risk (n=839) | Intermediate-risk (n=776) | High-risk (n=113) | |
|---|---|---|---|---|
| Median age (years) | 67 | 65 | 68 | 69 |
| Median NTDR | 31% | 31% | 32% | 32% |
| n (%) | n (%) | n (%) | n (%) | |
| NTDR≥33% | 424(24.5) | 183(10.6) | 203(11.7) | 38(2.2) |
| NTDR<33% | 1304(75.5) | 656(38.0) | 573(33.2) | 75(4.3) |
| PSA<10 ng/mL | 1448(83.8) | 839(48.6) | 548(31.7) | 61(3.5) |
| PSA 10–20 ng/mL | 237(13.7) | 0 | 228(13.2) | 9(0.5) |
| PSA >20 ng/mL | 43(2.5) | 0 | 0 | 43(2.5) |
| Gleason ≤6 | 1068(61.8) | 839(48.6) | 201(11.6) | 28(1.6) |
| Gleason 7 | 611(35.4) | 0 | 575(33.3) | 36(2.1) |
| Gleason 8–10 | 49(2.8) | 0 | 0 | 49(2.8) |
| T1 | 1217(70.4) | 699(40.5) | 463(26.8) | 55(3.2) |
| T2 | 484(28.0) | 140(8.1) | 313(18.1) | 31(1.8) |
| T3 | 27(1.6) | 0 | 0 | 27(1.6) |
| T4 | 0 | 0 | 0 | 0 |